Startseite UR
![]() | Eine Stufe nach oben |
, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter
, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
, Mason, Warren P., van den Bent, Martin J.
, Taphoorn, Martin J. B., Janzer, Robert C., Ludwin, Samuel K., Allgeier, Anouk, Fisher, Barbara, Belanger, Karl, Hau, Peter, Brandes, Alba A.
, Gijtenbeek, Johanna, Marosi, Christine, Vecht, Charles J., Mokhtari, Karima, Wesseling, Pieter
, Villa, Salvador
, Eisenhauer, Elizabeth, Gorlia, Thierry, Weller, Michael, Lacombe, Denis, Cairncross, J. Gregory und Mirimanoff, René-Olivier
(2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
The lancet oncology 10 (5), S. 459-466.
Volltext nicht vorhanden.
und Adema, Gosse J.
(2009)
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments.
Brain Pathology 19 (4), S. 674-693.
Volltext nicht vorhanden.
, Idema, Albert J., Bol, Kalijn F.
, Nierkens, Stefan
, Grauer, Oliver M., Wesseling, Pieter
, Grotenhuis, J. André, Hoogerbrugge, Peter M., de Vries, I. Jolanda M.
und Adema, Gosse J.
(2009)
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors.
Neuro-Oncology 11 (4), S. 394-402.
Volltext nicht vorhanden.
, Grauer, Oliver M., Brasseur, Francis, Hoogerbrugge, Peter M., Wesseling, Pieter
, Gidding, Corrie E., van de Rakt, Mandy W. M. M., Figdor, Carl G.
, Coulie, Pierre G., de Vries, I. Jolanda M.
und Adema, Gosse J.
(2008)
Selective cancer-germline gene expression in pediatric brain tumors.
Journal of Neuro-Oncology 88 (3), S. 273-280.
Volltext nicht vorhanden.
, Bennink, Erik, Toonen, Liza W.J., Boon, Louis, Wesseling, Pieter
, Sutmuller, Roger P.M. und Adema, Gosse J.
(2007)
CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
International Journal of Cancer 121 (1), S. 95-105.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707